Ticagrelor,Clopidogrel,Rivaroxaban,prasugrel
Janssen,AstraZeneca,Daiichi Sankyo,Eli Lilly,Bayer
['swap-ac', 'clopidogrel', 'swap,study', 'ticagrelor']
swap-ac study showed increased p2y12 reactivity but reduced thrombin generation, which translated into no differences in platelet-mediated global thrombogenicity b/w dpi and ticagrelor- &amp; prasugrel, but not clopidogrel-, based dapt #aha22 
Non-Profit Founder/Leader | ?? Doc | Artist | Scientist | Educator | News Anchor https://t.co/usmuA3tKft | RT ? endorse | Disclaimer: https://t.co/bwmE2O3U5W